Myristic Acid → Tetradecanoic acid, strontium salt (2:1)

HRID 225034

Reaktionsgleichung

Reaktionsgleichung von HRID 225034
[C:1]([OH:16])(=[O:15])[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH2:11][CH2:12][CH2:13][CH3:14].O.O.O.O.O.O.O.O.[OH-].[Sr+2:26].[OH-]>O>[C:1]([O-:16])(=[O:15])[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH2:11][CH2:12][CH2:13][CH3:14].[Sr+2:26].[C:1]([O-:16])(=[O:15])[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH2:11][CH2:12][CH2:13][CH3:14]

Komponenten

4

Reaktionsbedingungen

Temperatur
50 °C

Versuchsvorschrift

100 of myristic acid which has been granulated from an aqueous emulsion as described in Example 1 (AN 246, titer 53° C. particle size 0.2-0.3 mm.) and 60.2 g strontium hydroxide octahydrate (97% active) are suspended in one liter of water at 50° C. temperature and stirred for 30 minutes at 50° C. followed by 60 minutes of agitation at 70° C. The hollow formed granulate is filtered and dried. The content of free fatty acid amounts to 1.7%.

Aufarbeitung

  1. customtiter 53° C.
  2. waitfollowed by 60 minutes of agitation at 70° C
  3. filtrationThe hollow formed granulate is filtered
  4. customdried

Quellen und Nachweise

ORD-Eintrag
ord-0e0c9f328fc14207a0f5b0bbce5340c2
Quelldatensatz
uspto-grants-1980_11
Patentnummer
US04235794

Verknüpfte Notizen

Wird geladen…